This session, chaired by Dr Stuart Mcintosh from Queen’s University Belfast (UK), will focus on breast cancer research key strategic priorities now and in the future. Dr Kornelia Polyak from Dana-Farber Cancer Institute (USA), will share how her lab is striving to develop new ways to study tumours and apply interdisciplinary approaches to improve the clinical management of breast cancer patients. Dr Polyak’s lab has been at the forefront of studies analysing purified cell populations from normal and neoplastic breast tissue, to apply mathematical and ecological models for a better understanding of breast tumour evolution. She has also been successful with the clinical translation of her findings including the testing of efficacy of JAK2 and BET bromodomain inhibitors for the treatment of triple-negative breast cancer in clinical trials, and as a result, has received numerous awards for her outstanding research. During this conversation, the chair, Dr Stuart McIntosh, chair of the NCRI Breast Group and Consultant Breast Surgeon at Belfast City Hospital, will draw in the UK experience and the work the NCRI Breast Group do to develop research within the field. A session not to be missed by anyone interested and working in breast cancer research.

Who should attend?
Anyone interested or working in breast cancer research including patients and carers formally involved in research, scientists, medical/clinical oncologists, surgeons, early career researchers, nurses, allied health professionals, PhD and undergraduate students, research teams and research managers/funders


Jan 27 2022


1:30 pm - 2:15 pm